Pharmacoeconomics of inhaled anesthetic agents: Considerations for the pharmacist

American Journal of Health-System Pharmacy

Volumn 61, Issue SUPPL. 4, 2004, Pages

  Chernin, Eric L ^a  

^a SARASOTA MEMORIAL HOSPITAL   (United States)

Author keywords

Anesthetics; Blood levels; Concentration; Control; Costs; Density; Drug administration; Drug administration routes; Drug use; Duration of action; Molecular weight; Pharmacists; Pharmacoeconomics; Potency; Solubility; Tissue levels; Wastage

Indexed keywords

ANESTHETIC AGENT; DESFLURANE; ISOFLURANE; SEVOFLURANE;

CONFERENCE PAPER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG DELIVERY SYSTEM; DRUG POTENCY; DRUG SOLUBILITY; ECONOMIC ASPECT; FLOW RATE; GAS FLOW; HUMAN; MOLECULAR WEIGHT; OPERATING ROOM; PATIENT CARE; PHARMACIST; PRIORITY JOURNAL;

EID: 5444228126     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.suppl_4.s18     Document Type: Conference Paper

References (14)

1. Watcha MF, White PF. Economics of anesthetic practice. Anesthesiology. 1997; 86:1170-96.
2. Weiskopf RB, Eger EI II. Comparing the costs of inhaled anesthetics. Anesthesiology. 1993; 79:1413-8.
3. Dion P. The cost of anaesthetic vapours. Can J Anaesth. 1992; 39:633.
4. Beaussier M, Deriaz H, Abdelahim Z et al. Comparative effects of desflurane and isoflurane on recovery after long lasting anaesthesia. Can J Anaesth. 1998; 45(5 pt 1):429-34.
5. TerRiet MF, DeSouza GJ, Jacobs JS et al. Which is most pungent: isoflurane, sevoflurane or desflurane? Br J Anaesth. 2000; 85:305-7.
6. Suprane package insert. Deerfield, IL: Baxter Healthcare Corporation; 2001 Jan.
7. American Society of PeriAnesthesia Nurses. 2002 Standards of Perioperative Nursing Practice.
8. Mahmoud NA, Rose DJ, Laurence AS. Desflurane or sevoflurane for gynaecological day-case anaesthesia with spontaneous respiration? Anaesthesia. 2001; 56: 171-4.
9. Dexter F, Tinkler JH. Analysis of strategies to decrease post-anesthetic care unit costs. Anesthesiology. 1995; 82:94-101.
10. Dexter F, Coffin S, Tinkler JH. Decreases in anesthesia-controlled time cannot permit one additional surgical operation to be reliably scheduled during the workday. Anesth Analog. 1995; 81:1263-8.
11. Fazi L, Watcha MF. The economics of newer anaesthetic drugs: should we take the Rolls-Royce or the bicycle today? Paediatr Anaesth. 1999; 9:181-5.
12. White PF, Watcha MF. Pharmacoeconomics in anaesthesia: what are the issues? Eur J Anaesthesiol Suppl. 2001; 18: 10-5.
13. Powell PJ, Maland L, Bair JN et al. Implementing an operating room pharmacy satellite. Am J Hosp Pharm. 1983; 40: 1192-8.
14. Suttner S, Boldt J. Low-flow anaesthesia. Does it have potential pharmacoeconomic consequences? Pharmacoeconomics. 2000; 17:585-90.